CAR- T and cellular gene treatments are also costly

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and also innovation transfer can easily deliver cell gene therapies at an affordable cost to patients across the world.